LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹525 Cr | ₹463 Cr | ₹391 Cr | ₹373 Cr | ₹328 Cr |
What is the latest Total Current Assets ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹525 Cr |
| Mar2024 | ₹463 Cr |
| Mar2023 | ₹391 Cr |
| Mar2022 | ₹373 Cr |
| Mar2021 | ₹328 Cr |
How is Total Current Assets of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹525 Cr | 13.37 | |
| Mar2024 | ₹463 Cr | 18.37 | |
| Mar2023 | ₹391 Cr | 4.83 | |
| Mar2022 | ₹373 Cr | 13.85 | |
| Mar2021 | ₹328 Cr | - | |
Compare Total Current Assets of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,214.3 Cr | -3.8% | -17.2% | 8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -3.8% |
-17.2% |
8% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses